With several years of high-level experience, T. Daniel “Dan” Logan counsels clients on a variety of Food and Drug Administration (FDA) regulatory issues relating to the food, cosmetic, drug, dietary supplement, and tobacco company industries. Dan previously served as an Associate Chief Counsel in the Office of Chief Counsel of the FDA. In that role, Dan learned to navigate the intricacies of the Federal Food, Drug and Cosmetic Act, Administrative Procedure Act, Freedom of Information Act, and the Federal Advisory Committee Act, among others.
While at the FDA, Dan counseled subject matter experts, assessed evidence and policy rationales, and developed legal interpretations relating to FDA’s regulatory objectives. Additionally, during his time at the FDA, Dan worked with the Center for Tobacco Products and directed the center on rulemakings, program development, calculation and assessment of user fees, premarket review of tobacco products, and enforcement strategies. Dan also served as counsel for the FDA for investigations conducted by the Government Accountability Office and Office of the Inspector General of the Department of Health and Human Services.
Prior to joining Kleinfeld, Kaplan & Becker, Dan interned for the Hon. Sarah Evans Barker of the United States District Court for the Southern District of Indiana as well as the Hon. Mark Massa of the Indiana Supreme Court. He also interned at a medical device company and worked as a researcher in a molecular biology lab at the University of Pennsylvania’s Perelman School of Medicine, where he conducted research relating to the mechanisms of T-cell development and migration.
Publications & Speaking Engagements
- Presenter, “Overview of Food Law and Regulation”, FDLI Introduction to Food Law and Regulation Course (September 2021).
- “AMG Capital Management, LLC v. Federal Trade Commission,” Chapter Co-Author, Food and Drug Law Institute Top Food and Drug Cases, 2020 & Cases to Watch, 2021, May 2021.
- “Food Marketing Institute v. Argus Leader Media,” Chapter Author, Food and Drug Law Institute Top Food and Drug Cases, 2019, & Cases to Watch, 2020, October 2020.
- “FTC’s ‘Made In USA’ Rule Could Apply To Online Marketing,” Co-Author, Law360 (July 20, 2020).
- “CARES Act Will Accelerate OTC Drug Development,” Co-Author, Law360 (April 15, 2020).
- “Compliance with FDA’s Revised Nutrition Labeling Regulations: Nutrition labeling requirements for foods and supplements scheduled to take effect January 1, 2020,” Speaker, American Herbal Products Association (webinar), October 9, 2019.
- FDA Holds Public Hearing on Strategies to Address Youth E-Cigarette Use,” Editor, Update Magazine, Food and Drug Law Institute (April/May 2019).
- “JUUL in Schools: Can FDA Close the Youth On-Ramp While Still Maintaining the Off-Ramp for Adult Smokers?,” Co-Author, Update Magazine, Food and Drug Law Institute (December 2018/January 2019).
- Zlotoff, D.A., Zhang, S.L., De Obaldia, M.E., Hess, P.R., Todd, S.P., Logan, T.D., Bhandoola, A. (2011) Delivery of progenitors to the thymus limits T-lineage reconstitution after bone marrow transplantation. Blood 118, 1962-1970.
- Zlotoff, D. A., Sambandam, A., Logan, T. D., Bell, J. J., Schwarz, B. A., and Bhandoola, A. (2009). CCR7 and CCR9 together recruit hematopoietic progenitors to the adult thymus. Blood 115, 1897-1905.
- Chen, M. L., Logan, T. D., Hochberg, M. L., Shelat, S. G., Yu, X., Wilding, G. E., Tan, W., Kujoth, G. C., Prolla, T. A., Selak, M. A., et al. (2009). Erythroid dysplasia, megaloblastic anemia, and impaired lymphopoiesis arising from mitochondrial dysfunction. Blood 114, 4045-4053.
Recognition & Professional Activities
- Member, Cannabis-Derived Products Committee, Food and Drug Law Institute (2022)
- Member, Publications Peer Review Committee, Food and Drug Law Institute (2019-2021)
- Member, Food and Drug Administration Alumni Association
B.S., Haverford College
District of Columbia